Cube Biotech
Latest round
- Series A
Last raised
- Dec 2012
Total raised
- Undisclosed
Investors
- 1
About Cube Biotech
Cube Biotech GmbH, founded in 2012, is based in Monheim, Germany. The company specializes in providing solutions related to membrane proteins. Frank Schaefer, the founder, has been pivotal in establishing the company's strategic direction. In November 2021, ArchiMed acquired a majority stake in Cube Biotech from Creathor Ventures, strengthening its operational framework.Cube Biotech specializes in advanced protein-related solutions, focusing on the stabilization and purification of membrane proteins. Their core offerings include the flagship NativeMP™ Technology, designed to enhance the yield and functionality of membrane proteins by stabilizing them in their native environments. Additionally, the company provides a comprehensive suite of services such as protein purification, proteomics, and the production of cell-free lysates. These products cater primarily to research institutions, pharmaceutical companies, and biotechnology firms engaged in drug development and protein research, addressing critical challenges in protein handling and analysis.Cube Biotech's revenue model is structured around direct sales and customized service agreements within the B2B sector, primarily targeting research and development entities in the life sciences. Transactions typically involve clients ordering specific products such as the NativeMP™ Technology along with additional protein purification services tailored to their unique research needs. Pricing for products and services is generally structured around project scopes and specific client requirements, ensuring that each transaction aligns with the individual goals of the customer.Cube Biotech is focused on enhancing its product portfolio with upcoming innovations in protein stabilization technologies. The company aims to expand its presence in new markets, specifically targeting regions in Asia by the end of 2023. The recent acquisition by ArchiMed in November 2021 will support these initiatives, providing necessary resources for research and development as well as market penetration strategies.
Who invested in Cube Biotech
1 investor across 1 round
See all investors in Cube Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 13, 2012
Amount
Undisclosed
Investors
Questions about Cube Biotech
Who invested in Cube Biotech?
Cube Biotech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cube Biotech raised?
Cube Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cube Biotech last raise money?
Cube Biotech's most recent round on record is a Series A, in Dec 2012.
What does Cube Biotech do?
Cube Biotech GmbH, founded in 2012, is based in Monheim, Germany.
Where is Cube Biotech headquartered?
Cube Biotech is headquartered in Monheim, Germany.
Which VCs invest in companies like Cube Biotech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Cube Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Cube Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.